IP Library Granted Patent US 8,258,082
Granted Patent B2
US 8,258,082 · App. 13/250,520 · Granted Sep 4, 2012

Focused libraries of genetic packages

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,258,082
App. No.
13/250,520
Granted
Sep 4, 2012
Kind
B2
Abstract

Focused libraries of vectors or genetic packages that display, display and express, or comprise a member of a diverse family of antibody peptides, polypeptides or proteins and collectively display, display and express, or comprise at least a portion of the focused diversity of the family. The libraries have length and sequence diversities that mimic that found in native human antibodies.

Claims (35)

1. A focused library of vectors or genetic packages, comprising variegated DNA molecules, each of which comprises a DNA sequence that encodes an antibody heavy chain variable region having a CDR1 region, a CDR2 region, and a CDR3 region, wherein the variegated DNA molecules collectively encode a plurality of antibody heavy chain variable regions comprising heavy chain CDR3 motifs of:

xxxYCSSTSCxxx (SEQ ID NO:199), wherein each x independently is any amino acid or is absent;

xxxxYVWGSYxxx (SEQ ID NO:200), wherein each x independently is any amino acid or is absent;

xxxxxxxSGYxxx (SEQ ID NO:201), wherein each x independently is any amino acid or is absent;

xxxYDILTGYYxx (SEQ ID NO:202), wherein each x independently is any amino acid or is absent;

xxxVVVPAAxxxx (SEQ ID NO:203), wherein each x independently is any amino acid or is absent;

xxxYYDSSGYxx (SEQ ID NO:204), wherein each x independently is any amino acid or is absent;

xxxDFWSGxxxx (SEQ ID NO:205), wherein each x independently is any amino acid or is absent;

xxxTIFGVxxxx (SEQ ID NO:206), wherein each x independently is any amino acid or is absent;

xxxxIVATxxxx (SEQ ID NO:207), wherein each x independently is any amino acid or is absent;

xxxYGSGSYYx (SEQ ID NO:208), wherein each x independently is any amino acid or is absent;

xxxxYSYGxxx (SEQ ID NO:209), wherein each x independently is any amino acid or is absent;

xxxCSGxxCYx (SEQ ID NO:210), wherein each x independently is any amino acid or is absent;

xxxxAAAGxxx (SEQ ID NO:211), wherein each x independently is any amino acid or is absent;

xGxxxGGNxxx (SEQ ID NO:212), wherein each x independently is any amino acid or is absent;

xxxSGSYxxx (SEQ ID NO:213), wherein each x independently is any amino acid or is absent;

xxxSSSWxxx (SEQ ID NO:214), wherein each x independently is any amino acid or is absent;

xxxxTTVTTx (SEQ ID NO:215), wherein each x independently is any amino acid or is absent;

xxxC(SG)GDxCx (SEQ ID NO:216), wherein each x independently is any amino acid or is absent;

xxx(IV)AVAGxx (SEQ ID NO:217), wherein each x independently is any amino acid or is absent;

xxLWFGELxx (SEQ ID NO:218), wherein each x independently is any amino acid or is absent;

GxxWLxxxxF (SEQ ID NO:219), wherein each x independently is any amino acid or is absent;

xxxDTxMVxx (SEQ ID NO:220), wherein each x independently is any amino acid or is absent;

xxxxxGExxx (SEQ ID NO:221), wherein each x independently is any amino acid or is absent;

xxxxSGWxx (SEQ ID NO:222), wherein each x independently is any amino acid or is absent;

xxxxGYNxx (SEQ ID NO:223), wherein each x independently is any amino acid or is absent;

xxxVRGVxx (SEQ ID NO:224), wherein each x independently is any amino acid or is absent;

xxxIAAxxx (SEQ ID NO:225), wherein each x independently is any amino acid or is absent;

xxYxWNxxx (SEQ ID NO:226), wherein each x independently is any amino acid or is absent;

xxxYGDxx (SEQ ID NO:227), wherein each x independently is any amino acid or is absent;

xxVGATxx (SEQ ID NO:228), wherein each x independently is any amino acid or is absent; and

xxxYSSSx (SEQ ID NO:229), wherein each x independently is any amino acid or is absent.

2. The focused library of claim 1 , wherein the vectors are yeast vectors.

3. The focused library of claim 1 , wherein the genetic packages are yeast cells.

4. The focused library of claim 3 , wherein the yeast cells display the plurality of antibody heavy chain variable regions.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2021
From: DYAX CORP.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 056268/0983 →
RELEASE OF SECURITY INTEREST Recorded Oct 28, 2015
From: LFRP INVESTORS, L.P.
To: DYAX CORP.
Reel/Frame 036902/0703 →
SECURITY AGREEMENT Recorded Aug 22, 2012
From: DYAX CORP., A DELAWARE CORPORATION
To: LFRP INVESTORS, L.P., A DELAWARE LIMITED PARTNERSHIP
Reel/Frame 028828/0517 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2011
From: LADNER, ROBERT C.
To: DYAX CORP.
Reel/Frame 027431/0453 →